| Institution: | 1. Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China;2. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Central Laboratory, Peking University Cancer Hospital & Institute, Beijing, China;3. Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China;4. Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China;1. Breast Center, Department of OB & GYN and CCC Munich, LMU University Hospital, Munich, Germany;2. University of Pittsburgh/UPMC, NSABP Foundation, Pittsburgh, USA;3. Hospital General Universitario Gregorio Marañon, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain;4. Dana-Farber Cancer Institute, Boston, USA;5. Fudan University Shanghai Cancer Center, Shanghai, China;6. University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;7. National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan;8. Grupo Medico Camino S.C., Mexico City, Mexico;9. N.N.Blokhin Russian Cancer Research Center, Moscow, Russia;10. Mayo Clinic, Rochester, USA;11. Department of Medicine (Hematology/Oncology), University of California San Francisco, San Francisco, USA;12. Department of Oncology & Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland;13. Instituto D’Or de Pesquisa e Ensino (IDOR), Sao Paulo, Brazil;14. Rigshospitalet, Copenhagen, Denmark;15. National Cancer Center Hospital, Tokyo, Japan;16. IRCSS Ospedale Policlinico San Martino, UO Breast Unit, Genoa, Italy;17. Università di Genova, Department of Internal Medicine and Medical Specialties (DIM), Genoa, Italy;18. Medical University of Vienna, Vienna, Austria;19. Medizinische Hochschule Hannover, Hannover, Germany;20. Clin. Pesq. e Centro São Paulo, São Paulo, Brazil;21. Yonsei Cancer Center, Seoul, Korea;22. Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy;23. Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy;24. International Breast Cancer Center (IBCC), Madrid & Barcelona, and Vall d’Hebron Institute of Oncology, Barcelona, Spain;25. Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain;26. Sarah Cannon Research Institute/Tennessee Oncology, Nashville, USA;27. Eli Lilly and Company, Indianapolis, USA;28. Kyoto University Hospital, Kyoto, Japan;29. Royal Marsden NHS Foundation Trust, London, UK;30. Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, USA;1. Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China;2. School of Public Health, National Defense Medical Center, Taipei, Republic of China;3. Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Republic of China;4. Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China;1. Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA;2. International Breast Cancer Study Group Statistical Center, Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA;3. International Breast Cancer Study Group, Program for Young Patients, Coordinating Center, Effingerstrasse 40, Bern, 3008, Switzerland;4. Fertility and Procreation Unit, Gynecologic Oncology Program, European Institute of Oncology IRCCS, Via Ripamonti 435, Milan, 20141, Italy;5. Breast Cancer Center, Hospital Zambrano Hellion, School of Medicine, Tecnologico de Monterrey, Av. Batallon de San Patricio 112, San Pedro Garza Garcia, 66278, Mexico;6. International Breast Cancer Study Group, Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy;7. Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Medical Oncology Service, Barcelona, Spain;8. Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Toyama, Shinjuku-ku, Tokyo, 1-21-1, Japan;9. Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway;10. Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands;11. Department of Medical Oncology, Centre Oscar Lambret, Lille, France;12. Odette Cancer Center, Sunnybrook Health Sciences Center, Toronto, Canada;13. Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, Aurora, CO, USA;14. Department of Oncology, KU Leuven and Leuven Cancer Institute, Department of Obstetrics and Gynecology, University Hospitals Leuven, Leuven, Belgium;15. Center for Gynecologic Oncology Amsterdam, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam University Medical Center, Amsterdam, the Netherlands;p. Institut Jules Bordet and L''Universite Libre de Bruxelles, Brussels, Belgium;q. Breast Oncology Cancer, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan;r. Leon Berard Cancer Centre, Centre Léon Bérard, Department of Surgery, Lyon, France;s. Division of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia;t. St Luke''s International Hospital, Breast Center, Tokyo, Japan;u. Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Department of Clinical Research and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea;v. Cancer Trials Ireland and Medical Oncology Department, St. Vincent''s University Hospital and Tallaght University Hosptial, Dublin, Ireland;w. Hospital Virgen del Rocio Sevilla, GEICAM Spanish Breast Cancer Group, Sevilla, Spain;x. Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA;y. Division of Surgery, Faculty of Health and Medical Sciences, University of Western Australia, Crawley, WA, Australia;z. Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal;11. Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia;12. Breast Unit, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany;13. Medical University Graz, Department Gynaecology, Graz, Austria;14. Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA;15. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA;16. International Breast Cancer Study Group, IEO European Institute of Oncology, IRCCS, Milan, Italy;17. International Breast Cancer Study Group Statistical Center, Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Frontier Science and Technology Research Foundation, Harvard TH Chan School of Public Health and Harvard Medical School, Boston, MA, USA;18. Interdisciplinary Cancer Service Hospital Riviera-Chablais Rennaz, Geneva University Hospitals, Lugano University, Swiss Group for Clinical Cancer Research (SAKK), Vaud, Switzerland;1. Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina, USA;2. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA;3. School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA;4. Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA;5. H. W. Odum Institute for Research in Social Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA;6. Center for Nursing Excellence in Palliative Care, Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia, USA |
